Amanote Research
Register
Sign In
Comparative Outcomes of Basal Insulin and Oral Anti-Diabetic Agent as an Add-On to Dual Therapy in Patients With Type 2 Diabetes Mellitus
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.07.274
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
September 1, 2018
Authors
T Chang
H Lin
F Lin
Publisher
Elsevier BV
Related search
Observational Study of the Use of Insulin Glargine as Basal Therapy in Patients With Type 2 Diabetes Mellitus in Morocco
Journal of Endocrinology and Metabolism
Endocrinology
Metabolism
Diabetes
Erratum To: Evaluation of Add-On Therapy of Sitagliptin in Japanese Patients With Type 2 Diabetes Under Insulin Therapy
Diabetology International
Internal Medicine
Endocrinology
Metabolism
Diabetes
BeAM Value: An Indicator of the Need to Initiate and Intensify Prandial Therapy in Patients With Type 2 Diabetes Mellitus Receiving Basal Insulin
BMJ Open Diabetes Research and Care
Endocrinology
Metabolism
Diabetes
The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients
IOSR Journal of Dental and Medical Sciences
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or Prandial Insulin? The APOLLO Trial and Beyond
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Effect of Switching Basal Insulin Regimen to Degludec on Quality of Life in Japanese Patients With Type 1 and Type 2 Diabetes Mellitus
Journal of Pharmaceutical Health Care and Sciences
Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-On Therapy in Chinese Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
U-500 Insulin as a Component of Basal Bolus Insulin Therapy in Type 2 Diabetes
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
